Advancing Targeted Therapies for Ovarian Cancer Kaida BioPharma is focused on advancing KAD-101 through the next stage of clinical development. Learn About KAD-101 Seeking the First VictoryAgainst Ovarian Cancer Click Here to watch the replay of our Virtual Investor Pitch Presentation
